TailorMed bolsters leadership team with three strategic hires

Israeli startup TailorMed Medical, which has developed patient financial navigation technology that helps health care organizations and patients, announced three new additions to its leadership team on Monday. The company appointed Naama Geva as Chief Financial Officer (CFO), Vince King as Chief Commercial Officer (CCO), and Noa Inbar-Hershkovits as Vice President of People.

Geva brings more than 10 years of financial leadership at high-growth startups. Prior to joining TailorMed, Geva served as CFO for four years at Deep Instinct, a global cyber security company that secured over $200 million in funding and has grown to over 250 employees. Geva will establish financial and business infrastructure.

King has built a strong track record of growing healthcare technology companies over the past 20 years. Most recently, King served as Chief Commercial Officer for SCI Solutions (SCI), acquired by R1 RCM. At SCI, he led the company’s transformation to a Digital Patient Experience SaaS provider, resulting in new market expansion. King will oversee commercial functions including sales, marketing, and strategic partnerships to accelerate company growth.

Inbar-Hershkovits brings 15 years of global human resources (HR) experience in both fast-growing startups and corporate organizations. Inbar-Hershkovits held various HR leadership roles, most recently at Amazon and AlgoSec. Inbar-Hershkovits will lead all HR-related activities, including creating the necessary infrastructure and resources to help grow the organization.

"These are exciting times at TailorMed. Our new leadership adds to the momentum we’re gaining in the market," says Srulik Dvorsky, CEO and Co-Founder of TailorMed. “Our ability to attract this level of talent speaks to our innovative culture that’s focused on moving mountains for patients. Our TailorMed team will continue to grow with more top-tier talent as we advance our market leadership."

TailorMed announced in September that it had extended its round of funding, increasing the overall investment by $5 million to $25 million. New strategic investors included the American Cancer Society’s impact investment fund, BrightEdge, OSF Healthcare’s corporate investment arm, OSF Ventures, and Citi via their Citi Impact Fund. Sanara Capital, Sanara Ventures’ follow-on fund, also participated.